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ABSTRACT
(57 )
The present invention is directed to methods for forming
microparticles useful for cell seeding and for conjugating
protein to the surface of the microparticles. The method
comprises co -injecting an organic solution of PLGA or other
polymer with an aqueous solution into a flow focusing tube .
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METHOD OF FORMING MICROPARTICLES
FOR USE IN CELL SEEDING
CROSS -REFERENCE TO RELATED
APPLICATIONS
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ducted at a speed from 100 to 300 rpm . In yet other aspects

of the invention , the second aqueous solution is further
stirred after the introducing step .

[0009 ] In some aspects of the invention , the PLGA

microparticles are lyophilized . In other aspects of the inven

tion , the PLGA microparticles are stretched into microdisks

[0001 ] This application is based on and claims priority to
U . S . Provisional Application Ser. No. 62 /318 , 837 , filed on
Apr. 6 , 2016 , which is incorporated herein by reference in its

method of conjugating a cell binding protein to surfaces of

STATEMENT REGARDING FEDERALLY

some such aspects of the invention , the PLGA micropar

entirety .

SPONSORED RESEARCH OR DEVELOPMENT

and microrods.
[0010 ] Other aspects of the invention are directed to a

poly ( D ,L - lactide -co -glycolide ) (PLGA ) microparticles. In
ticles comprise PLGA- PEG microparticles. In some aspects

of the invention , the process includes obtaining PLGA

[0002] Not applicable .
BACKGROUND OF THE INVENTION

microparticles formed from the process of claim 1. The

1. Field of the Invention
[0003 ] The present invention is directed to the field of
microparticle formation for use in growing cells .

protein is added at a pH above 7 .0 . The protein and PLGA
microparticles are shaken to conjugate the protein to the
surfaces of the PLGA microparticles, and unreacted reagents
are removed . In some aspects of the invention , the shaking
step is combined with or followed by deaggregating the

2 . Description of Related Art
[ 0004 ] Cell therapy is an emerging strategy to replace or
repair severely damaged tissues with cultured cells . How

ever, structural supports are required for cells to form the
tissue. Biodegradable porous polymeric microparticles have

been studying as scaffolds for cell growth .
BRIEF SUMMARY OF THE INVENTION
[ 0005 ] One aspect of the present invention is directed to a

method for formingmicroparticles useful for cell seeding . In

one such aspect, the method includes obtaining an organic

solution

comprising

poly( D ,L -lactide-co - glycolide )

( PLGA ), obtaining a first aqueous solution comprising poly
vinyl alcohol (PVA ) and obtaining a second aqueous solu

tion comprising PVA in a higher concentration than said first
aqueous solution . The organic solution and a carrier stream

of the first aqueous solution are injected into a flow focusing

tube to form organic droplets within the carrier stream . The
carrier stream comprising the organic droplets is introduced
into the second aqueous solution to form microparticles of

the PLGA in the second aqueous solution . The organic
solvent is evaporated and the PVA is removed .
[0006 ] In some aspects of the invention , the ratio of the

PLGA to the organic solvent is from 1 % ( w / v ) to 25 % ( w / v ) ,

or from 5 % (w /v ) to 15 % (w /v ). In some aspects of the
invention , the organic solution comprises PLGA and poly
ethylene glycol (PEG ). In some such aspects, the ratio of

PLGA to PEG is 70 : 1 or greater .
[0007] In some aspects of the invention the concentration
of PVA in the first aqueous solution is from 1 % (w / v ) to 10 %

( w /v ), and the concentration of PVA in the second aqueous
solution is from 1 % (w /v ) to 10 % ( w /v ). In other aspects of

the invention , the ratio of the organic solution to the first
aqueous solution is 1 : 1 to 1 : 10 , or 1 : 2 to 1 : 4 . In yet other

PLGA microparticles are suspended in an aqueous buffer
surfaces of the PLGA microparticles are activated , and

solution at pH from 5 .5 to 6 .5 . The carboxyl groups on the

mixture . In other aspects of the invention , the unreacted

reagents are removed by centrifugation , filtration or combi

nations thereof
[0011] In some aspects of the invention , the ratio of the
PLGA microparticles to the buffer solution is 1: 1 to 25 : 1

( w / v ). In other aspects of the invention , the protein is

selected from the group consisting of fibronectin , gelatin ,

collagen , laminin and peptides .

[0012 ] Additional aspects of the invention , together with

the advantages and novel features appurtenant thereto , will
be set forth in part in the description which follows, and in
part will become apparent to those skilled in the art upon

examination of the following , or may be learned from the

practice of the invention . The objects and advantages of the
invention may be realized and attained by means of the

instrumentalities and combinations particularly pointed out
in the appended claims.

BRIEF DESCRIPTION OF THE DRAWINGS
[0013] FIG . 1 depicts scanning electron microscope
(SEM ) images of PLGA microparticles of ~ 100 um diam
eter.

[0014 ] FIG . 2A depicts SEM images of PLGA micropar
ticles .
[0015 ] FIG . 2B depicts SEM images of PLGA -Gelatin
(Gel) microparticles .
[0016 ] FIG . 2C depicts SEM images of PLGA - fibernectin
(FN ) microparticles .
[0017 ] FIG . 2D depicts SEM images of PLGA-Gel- FN
microparticles.
[0018 ] FIG . 2E depicts SEM images of PLGA-polyethyl
eneglycol (PEG )-Gel microparticles .
[0019 ] FIG . 2F depicts SEM images of PLGA -PEG - FN

from 1 : 1 : 5 to 1 : 5 :25 .

microparticles.
[0020] FIG . 3 depicts SEM , fluorescence microscopy, and
Bright field microscopy of PLGA - gelatin disk micropar

[ 0008 ] In some aspects of the invention , the introducing
step comprises submerging an outflow end of the flow
focusing tube in the second aqueous solution . In other
aspects of the invention , the introducing step comprises
stirring the second aqueous solution , which may be con -

[0021 ] FIG . 4 depicts SEM images of rod shaped
microparticles.
[0022 ] FIG . 5 is a graph of zeta potential of various
particle types.

aspects of the invention , the ratio of the organic solution to

the first aqueous solution to the second aqueous solution is

ticles .
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[0023 ] FIG . 6 depicts fluorescence microscope images of

solvent will then slightly diffuse into the first aqueous
solution . The mixture is introduced into the second aqueous

types.

a hardening bath to maintain the size of the microparticles .

cell lines grown on various particle types .
[0024 ] FIG . 7 is a graph of cell growth on various particle
DETAILED DESCRIPTION OF PREFERRED

EMBODIMENT

[0025 ] The present invention is directed to methods of
forming microparticles useful for cell seeding and for con

jugating protein to the surface of the microparticles.

[ 0026 ] One aspect of the invention is directed to methods
of forming microparticles using a flow focusing device . The

method comprises obtaining an organic solution comprising
a biodegradable and biocompatible polymer, such as poly

( D , L -lactide - co - glycolide ) (PLGA ). Two aqueous solutions

comprising a surfactant, such as polyvinyl alcohol (PVA ),
are also obtained . The organic solution is co -injected with a
stream of the first aqueous solution , referred to herein as a

" carrier” stream , into a flow focusing tube . The combined
streams are introduced into the second aqueous solution to

solution , having a higher concentration of PVA , which acts

If left open to the atmosphere , the organic solvent will
polymer particles. Several variables can be modulated to
control the size of these particles . These variables include :
method of combining the organic and aqueous phases ,
intensity of mechanical agitation upon addition , length of
agitation time, length of evaporation time, organic solvent,
polymer species, polymer concentration , emulsifier addi
evaporate out of the mixture , leaving behind spherical

tives in the aqueous phase , concentrations of emulsifiers ,
relative amounts of the two phases , ambient conditions , and
other variables that will be understood by those of ordinary
skill in the art .

[0031 ] The concentration of PVA in both the first and

second aqueous solutions is preferably from 1 % to 10 %
( w / v ). The concentration of PVA in the second aqueous
solution may be higher than the concentration of PVA in the

solution . The organic solvent is then evaporated and the PVA

first aqueous solution Lower PVA concentrations make
larger microparticles, whereas higher PVA concentrations

removed .

the first aqueous solution is preferably less than 5 % , pref

form microparticles of the PLGA in the second aqueous

[ 0027 ] The biodegradable and biocompatible polymer is
preferably PLGA . However, other polymers , for example
polycaprolactone (PCL ) in dichloromethane (DCM ), can
also be used . Also , PLGA may be combined with polyeth
ylene glycol (PEG ) or other polymers . The PEG is prefer
ably physically adsorbed to PLGA microparticles. Although
PLGA will be referred to in the following description , it
should be understood that the description also applies to
other polymers and polymer combinations .
[0028 ] The organic solvent can generally be any organic

solvent. Exemplary organic solvents include halogenated
hydrocarbons (e . g . chloroform and dichloromethane ), ethyl

acetate, acetone, dioxin and tetrahydrofuran . In some
embodiments , ethyl acetate is used . The ratio of PLGA to

solvent is preferably 1 % to 25 % ( w /v ) ( e .g . 10 mg/mlto 250
mg/ml), more preferably 5 % to 15 % , and most preferably

7 % to 12 % . In some embodiments, the PLGA is present at

200 mg/ml, or approximately 10 % ( w / v ). When a second
polymer such as PEG is present, the ratio of PLGA to PEG

is preferably greater than 70 : 1 (w /w ), more preferably

greater than 80 :1 (w /w ) and most preferably around 90 : 1
[0029 ] The aqueous solutions comprise a surfactant. PVA

from smaller microparticles . The concentration of PVA in
erably, less than 3 % ,more preferably around 1 % ( w /v ) and

the concentration of PVA in the second aqueous solution is

preferably greater than 5 % , preferably greater than 8 % ,

more preferably around 10 % ( w /v ). The first and second
aqueous solutions may comprise the same surfactant and

same aqueous solvent.

[0032 ] The organic solution and first aqueous " carrier"
solution are co - injected into a flow focusing device using

any suitable method , as will be understood by one of

ordinary skill in the art. A stream of the organic solution and
a carrier stream of the first aqueous solution may be co
injected using a pump (s ), such as a two -syringe pump, in
which the two syringes are filled with the organic solution

and first aqueous solution , respectively . The pump can

maintain the flow rate of the solutions , which assists with

homogeneous production of microparticles .

10033 ] Co -injecting the organic solution and carrier aque
ous solution results in the formation of organic droplets in
the carrier aqueous solution , as described above. The ratio of
the organic solution to the first aqueous solution is prefer

( w / w ).

ably 1 : 1 to 1 : 10 , more preferably is 1 : 2 to 1 : 4 ( v / v ). In some

is a commonly used surfactant that has been shown to be

aqueous solution is 3 : 10 ( v /v ).

useful in the present invention , although other surfactants

can also be used . Although PVA will be referred to in the

following description , it should be understood that the

embodiments, the ratio of the organic solution to the first
10034 ] The flow focusing tube into which the stream of
organic solution and carrier stream of carrier aqueous solu

tion are co -injected can be any tube suitable for such

description also applies to such other surfactants .
[0030 ] The aqueous solutions can generally comprise any

purpose . In some embodiments , the tube is from 9 to 12
inches in length and 0 . 1 to 0 . 4 inches , preferably 0 . 2 to 0 . 3
inches, in diameter. A Pasteur pipette, such as a 9 inch
Pasteur pipette , can be used consistent with the invention .
[0035 ] The carrier stream comprising the organic droplets

solution acts as a carrier stream when co - injected with a

suitable method , as will be readily understood by one of

stream of the organic solution . When the organic solution
and first aqueous solution are co - injected , the organic solu

ordinary skill in the art. In some embodiments, the outflow

aqueous solvent. Water can be used consistent with the
present invention , and use of reverse osmosis (RO ) water
prevents any external debris during microparticle synthesis.
Two aqueous solutions are provided . The first aqueous
tion forms organic droplets within the carrier stream . More

specifically , when a fixed amount of the organic solution is
mixed with a larger volume of the first aqueous solution ,

emulsification will spontaneously occur, thus creating
spherical droplets of the organic solution . The organic

can be introduced into the second aqueous solution by any
end of the flow focusing tube is submerged in the second
aqueous solution . The second aqueous solution may be

stirred during the introducing process . The second aqueous
solution may be stirred at 100 to 300 rpm , and in some
embodiments is stirred at around 250 rpm . The time for

which the introducing step is carried out can vary depending

US 2017 /0292109 A1
on the v /v ratio and flow rates. In some embodiments , the
introducing step is carried out for three minutes. The ratio of
organic solution to the first aqueous solution to the second
aqueous solution is preferably from 1: 1:5 to 1:5 :25 ( v/v /v ).
In some embodiments the ratio is 3 :10 :75 (v /v /v ).
[0036 ] When the carrier stream comprising the organic
droplets is introduced into the second aqueous solution ,
microparticles of the PLGA are formed in the second
aqueous solution . The microparticles are generally spherical
in shape. The method of the present invention can produce
PLGA microparticles with varying sizes , including sizes

ranging from 100 - 300 um , including 150 - 250 um .
[ 0037 ] After the carrier stream is introduced into the
second aqueous solution , the solution can be further stirred

for a period of time. For example , the second aqueous
solution can be stirred for 15 to 60 minutes after the carrier

stream is introduced .
[0038] The organic solvent is then evaporated . The solvent

may be evaporated at room temperature. In such embodi

ments, the evaporation is preferably carried out for 18 or
more hours .

[ 0039 ] The process also preferably includes removing the
PLA . In some embodiments , the PLA is removed by cen
trifugation , which may be followed by water washes. The

remaining PLGA microparticles may then be lyophilized .
[0040 ] In certain applications it is desirable to produce

PLGA microparticles with different shapes . Non -spherical
PLGA microparticles can be produced by stretching the
PLGA microparticles into microdisks and microrods.
Stretching can be carried out according to the methods
described in Ho, C . C ., et al.: Preparation ofmonodisperse
ellipsoidal polystyrene particles. Colloid and Polymer Sci
ence, 271, 469- 479; Champion , J. A .; Mitragotri, S .: Role of
target geometry in phagocytosis. Proceedings of the

National Academy of Sciences of the United States of

America 2006 , 103, 4930 -4934 ; and Barua , S ., et al.: Particle
shape enhances specificity of antibody -displaying nanopar
ticles. Proceedings of the National Academy of Sciences of
the United States of America 2013 , 110 , 3270 -3275 which
are incorporated herein for purposes of such disclosure .
[0041] A second aspect of the invention is directed to a
method of conjugating a cell binding protein to surfaces of
microparticles. The process can be used with the micropar
ticles formed by the process of the present invention , or with

biodegradable soft polymeric microparticles formed by

other processes . Although PLGA microparticles will be
referred to in the following description , it should be under

stood that the description also applies to other micropar

ticles .

0042] Microparticles, such as the PLGA microparticles
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[0043 ] The carboxyl groups on the surfaces of the PLGA

microparticles are then activated. The activation may

include addition of synthetic groups such as isothiocyanates,

isocyanates, acyl azides, NHS esters, sulfonyl chlorides ,
aldehydes , glyoxals, epoxides, oxiranes, carbonates, aryl
halides , imidoesters, carbodiimides, anhydrides , and fluoro
phenyl esters , or other suitable groups, as will be readily

understood by one of ordinary skill in the art. In some
embodiments , the carboxyl groups are activated by succes

sive additions of 1 - Ethyl-3 -( 3 -dimethylaminopropyl)carbo
diimide (EDC ) and N -hydroxysuccinimide (NHS ) to pro
duce an amine -reactive NHS ester on the surfaces of the
PLGA microparticles. For example, activation of carboxyl
groups on the PLGA microparticle surface can be accom
plished through the successive additions of 4 mg of EDC and
6 mg of NHS to yield an amine - reactive NHS ester .
[0044 ] The protein is then added to form a mixture of the
microparticles and the protein . Prior to addition of the
protein the pH is adjusted , preferably to above 7 .0 , more
preferably to above 7 . 2 and in some embodiments to around
7 .4 . Prior to adding the protein , a portion of the buffer
comprising a mass of the microparticles in the desired
amountmay be removed from the buffer solution for protein
addition . The protein may be any cell binding protein , as will
be recognized by one of ordinary skill in the art. Suitable
proteins include fibronectin , gelatin , collagen , laminin and
peptides. In some embodiments , the ratio of protein to

microparticles can be 0 .01: 1 to 1 :1 , and in some embodi
ments is around 0 . 05 : 1 ( w / w ). Fibronectin is a natural

glycoprotein originating on the extracellular matrix of
embryonic and adult tissues that binds to the aß, receptor

on cell surface. Fibronectin aids in cell adhesion through

specific receptor ligand interactions . It helps wound healing
with the help of adherent fibroblast cells , fibrin cross - linker
and collagen fibrils .

[0045 ] Themixture is then shaken to conjugate the protein

to the surfaces of PLGA microparticles . At lower tempera
tures , longer incubation times are required. For example , at
4° C ., the shaking may be carried out for 10 hours , whereas
at 25° C ., the reaction time could be reduced down to 2
hours. The shaking may be carried out at around 450 rpm .

The mixture may be deaggregated , for example by using
polyethylene glycol (PEG ) to the mixture . PEG may be

added to a final concentration of 0 .001% PEG .
[0046 ] Unreacted reagents may then be removed .

Removal of unreacted reagents can be accomplished using

centrifugation , filtration or combinations thereof, and may

be accompanied by water washes to achieve pure, protein
conjugated microparticles .
[0047] The present invention provides a new method of
polymer microparticle synthesis, and non -spherical

an aqueous buffer solution . The buffer solution preferably

microparticle formation for growing cells on the surface of
microparticles . The present invention enables synthesis of

embodiments , around 6 . 0 . The ratio of the PLGA micropar

using a single emulsion solvent evaporation method which
utilizes a flow - focusing device . Using the flow - focusing

formed from the process described above , are suspended in

has a pH from 5 .5 to 6 . 5 , preferably 5 .7 to 6 .3 and in some
ticles to the buffer solution can be 1 : 1 to 25 : 1 (w / v ), 5 : 1 to
15 : 1 , and in some embodiments around 10 : 1 ( w /v ). Any

suitable buffer may be used , as will be readily understood by

PLGA microparticles of a desired size (e.g . 150 - 200 um )
devices facilitates production of particles of desired size , in

a short amount of time. It has been found 150 mg of

one of ordinary skill in the art. A buffer comprising (mor

microparticles in the 150 - 200 um range can be produced in

pholino )ethanesulfonic acid (MES ) and NaCl is suitable for
use with the invention . In some embodiments, 50 mg of
PLGA microparticles may be suspended in 5 ml of an

under two hours, whereas other existing methods have had
24 hours for production . The process of the invention can be
scaled up tenfold to produce 1 . 5 g of particles by increasing
the poly (vinyl alcohol) (PVA ) hardening bath to 1 L , and the

aqueous activation buffer comprising 0 . 1 M 2 -mES and 0 . 5

M NaCl with an adjusted pH of 6 .0 .

trouble reaching this size of particle and have required over
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time required would not increase. The microparticle synthe -
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removed , and the emulsion was stirred for an additional 15

sis method of the invention does not require a custom -built

minutes. The mixture was left undisturbed overnight (> 18

temperature ionic liquids). Additionally,multiple syntheses
could be conducted in tandem to increase production dra
matically , while still minimizing personnel. Particles are

spheres were then lyophilized , weighed, and stored at 4° C .

apparatus or chemically complex solutions ( e . g . salt/protein
solutions for stabilization of double emulsions, or room

currently produced at a rate of 2000 particles per dollar.
[ 0048 ]. The method of the present invention prepares

layer -by -layer microparticles with a PLGA core, and
fibronectin ( or other protein ) and/ or polyethylene glycol
polymer on the surface of the PLGA , using one-step single
emulsion . Conventional batch emulsification requires at

least two steps in which internal droplets of particles are

formed in surfactant 1 at step 1 for at least 24 h followed by
outer droplet formation by shear at step 2 with an additional

24 h . In the method of the present invention , both surfactant
and particle mixtures are added at the same time in less than

an hour. The parallel streams of particles and surfactants are

focused through a constriction that breaks up into droplets
through the gap .
[0049] The present invention can produce particle geom

etries that are important for eliciting cell alignment to dictate
tissue microarchitectures and biological functions. The

aligned organization of cells is important to regulate cell
matrix organization . As described in Example 3 , below , the
PLGA microparticles with three different topographical
geometries where shown to proliferate in an in vitro biore

actor that provides an effective approach to provide appro

priate cushioning for cell survival . While there has been an

interest in growing cells on various shapes ofmicroparticles,

synthesis of monodisperse spherical PLGA microparticles

and non -spherical shape PLGA particles has been a chal
used in spherical and non -spherical microparticle synthesis.
[ 0050 ] Certain aspects of the invention are illustrated by
the following non - limiting examples.
Example 1: Microparticle Formation
[0051] Synthesis of PLGA Microparticles

lenge . The invention includes a new technique that can be

[0052] Firstly , an organic solution was formulated by

dissolving 200 mg of Poly ( D , L - lactide- co - glycolide )

(PLGA ; Acros Organics, ~ 19 kDa) in 3 ml of ethyl acetate
(Fisher Scientific ). Aqueous solutions of 1 % and 10 % ( w /v )
polyvinyl alcohol (PVA ; Sigma-Aldrich , 30 -70 kDa ) were

formed by dissolving PVA in reverse osmosis ( RO ) water. A

flow - focusing apparatus was assembled with 3 and 10 ml
syringes , a two - syringe pump (kdScientific , KDS- 200 ), plas
tic tubing, a Pasteur pipette , and a stir plate . The 3 and 10 ml
syringes were completely filled with the PLGA and 1 % PVA
solutions , respectively ; these represent the organic and the

aqueous carrier streams of the flow - focusing apparatus.

[ 0053] By using an equal drive block velocity on both
syringes , the two streams were injected into the Pasteur
pipette at a 3 : 10 flow rate differential. With careful adjust

ments, gently forcing the organic stream tubing into the
pipette neck produced regularly - sized organic droplets sur

hours ) to allow for evaporation of residual ethyl acetate at
room temperature . PVA was removed by centrifugation at
7 , 000 rcf, followed by five washes with RO water. Micro

PLGA microspheres were stretched to microdisks and

microrods by the film stretching technology.
[0054 ] Synthesis of PLGA -PEG Microparticles
10055 ] PLGA -PEG microparticles were prepared using a

modified version of the single emulsion -solvent evaporation
technique, utilizing a flow - focusing apparatus as described
above. PLGA particles with physically adsorbed PEG were
prepared in the samemanner but at a PLGA :PEG ( w /w ) ratio
of 90 : 10 , thus 180 mg of PLGA and 20 mg of PEG were
used . An aqueous solution comprising of 1 % (w / v ) polyvi
nyl alcohol (PVA ; Sigma-Aldrich , 30 -70 kDa, 87 - 90 %
hydrolyzed ) was formed by dissolving PVA in reverse
osmosis (RO ) water.

Example 2 : Protein (Fibronectin or Gelatin )
Conjugation to the Surface of PLGA and
PLGA -PEG Microparticles
[0056 ] Bovine fibronectin (R & D Systems) and gelatin
were conjugated to the surface of PLGA microparticles,
including PLGA -PEG microparticles, by coupling primary
amines of fibronectin with carboxyl groups of PLGA to form
amide bonds (NHS and Sulfo -NHS Instructions , Thermo
Scientific ). Briefly, 50 mg ofmicroparticleswere suspended
in 5 ml of an aqueous activation buffer : 0 . 1 M 2 - mor
pholino) ethanesulfonic acid (MES ; Sigma-Aldrich ) and 0 .5
M NaCl (Fisher Scientific ) with an adjusted pH of 6 .0 .
Activation of carboxyl groups on the PLGA microparticle
surface was accomplished through the successive additions
of 4 mg of 1 -Ethyl-3 -( 3 -dimethylaminopropyl) carbodiimide
(EDC ; Thermo Scientific ) and 6 mg of N -hydroxysuccin
imide (NHS; Thermo Scientific ) to yield an amine- reactive
NHS ester. After increasing the mixture pH above 7 .0 , a

volume containing the desired particle mass for cell seeding

was removed , and fibronectin and gelatin were added to this
volume at a ratio of 0 .05 mg fibronectin /mg particles . This

mixture was shaken overnight (> 10 hours) at 450 rpm and 4°
C.

[0057) Todisperse aggregations formed during the shaking

process , and sufficient polyethylene glycol (PEG ; USP ) was
added to make the mixture 0 . 001 % PEG . Unreacted reagents
were removed by centrifugation at 1 ,000 rcf, followed by 3

washes with sterilized RO water , and subsequent filtration
through a 100 kDa filter (EMD Millipore Amicon Ultra - 4 ).
The supernatants were combined , and unconjugated
fibronectin was quantified with the Bradford protein assay

( Thermo Scientific ) using bovine serum albumin (BSA ) as
the standard . Fibronectin -conjugated particles were stored in
PBS at 4° C . and used for cell seeding within one week .
Example 3: Microparticle Characterization
[0058 ] The shape , size , and surface topography of

rounded by the aqueous carrier stream in the pipette capil
lary . The Pasteur pipette was positioned vertically above 75

microparticles were analyzed with SEM at 1 - 10 kV and

rpm ) such that the pipette tip was just submerged near the
center of the solution 's vortex whorl. For 3 minutes of

150x to 250x magnification (Hitachi S -4700 ) and stereo
microscopy (Hirox KH -8700 ). Particle size and shape were
also visualized with bright field microscopy (Nikon Eclipse

tinuous aqueous phase . The Pasteur pipette was then

water and phosphate buffer saline (PBS; Fisher Scientific )

mlof the 10 % PVA solution (stirring at approximately 250
injection , the organic droplets were dispersed into the con -

E400 ) . The microparticle surface charge was measured in
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with dynamic light scattering (DLS; Malvern NanoSeries

Zetasizer ZS90 ). DLS measurements were performed at 25°
C . in disposable capillary cells (Malvern ) using the back

scattering detection at 90°. The zeta potential was measured
for 20 successive runs . Data was analyzed usingmeans and
standard deviations of three measurements .
10059 ] Results

[ 0060 ] SEM images of particle formulations useable in
cell seeding are shown in FIG . 1 ( PLGA microspheres with
average particle diameter 183 + 70 um ), and FIGS. 2A

zeta potential of themicroparticles was determined using a
Nanoseries Zetasizer. Zeta potential was measured by dilut

ing particles to a concentration of 3 mg/ml and measuring
the electrophoretic mobility of the particles in RO water and

phosphate buffered saline ( PBS ). Standard deviation was

determined by n = 3 trials for each microparticle. Results are
shown in Table 3 , below and FIG . 5 . The zeta potential was
found to be -25.9 + 4 .8 mV in deionized water (DIH2O ) and
- 6 . 3 11.8 mV in PBS of pH 7 .4 .

( PLGA ), 2B (PLGA -Gelatin (Gel)), 2C (PLGA-fibernectin

TABLE 3

(FN ) ), 2D (PLGA -Gel- FN ) , 2E (PLGA - polyethyleneglycol
(PEG ) -Gel) and 2F (PLGA -PEG - FN ). FIG . 3 depicts in

Zeta Potential of Particle Types

panels ( A ) and (B ) SEM images of PLGA -Gelatin disk

Particle

um ; width : ~ 2 surface area (S . A . ): ~ 10 ,000 um . Panel ( C )

PLGA
PLGA -Gel

FITC dye conjugated PLGA disks , and panel (C ) depicts

PLGA - FN
PLGA -PEG
PLGA -PEG -Gel

shape microparticles of the following dimensions: 81 : 26

of FIG . 3 depicts results of Fluorescence microscopy of

results of bright field microscopy of PLGA -gelatin disks

microparticles . FIG . 4 depicts PLGA rod shaped micropar
ticles of length of ~ 30 um , width 8 + 1. 7 um , and S . A . of

PLGA - PEG - FN

$ (mV) in H ,0
- 25 .9 + 4. 80 mV
- 19 . 9

8 .02 mV

- 15 . 1 £ 6 .9 mV
- 46 . 3 + 6 .88 mV
- 46 . 2 + 6 . 94 mV
- 42. 7 + 5 .64 mV

$ (mV) in PBS
- 6 .26 = 11 .8 mV
- 16 . 0 + 18 .6 mV
- 27. 4 + 9 . 89 mV

- 9. 49 16 .9 mV
- 26 .0 + 11.9 mV
- 31 . 1 + 13 . 3 mV

~ 570 um ' .

[0061] Adding fibronectin increased particle stability and

Example 3: Cell Growth of Microparticles In Vitro

eter was determined using ZENPro imaging software which
was package with the Zeiss Axis confocal microscope .

[0064 ] Whether model cell line human umbilical vascular
endothelial cells (HUVEC ) attach to microparticles in sus
pension was investigated .HUVEC were cultured in Medium
200 containing low serum growth supplement (LSGS ) and
1 % penicillin / streptomycin at 37° C . and 5 % CO2. Cells
were grown , and sub - cultured using the standard method . To
this end, the appropriate ratio of cell to particle numbers was

increased particle size significantly . Average particle diam

Standard deviations were performed with at least n = 50
a known correlation (REF) based on polymer density and
average particle diameter, as shown in Table 1.

particles . Number ofparticle per gram was determined using

determined . The surface area ratios of cells to microparticles
were calculated theoretically . A surface area ratio of 10 was
reasonable . 1x100 HUVEC were seeded on 10 % number of

TABLE 1
Average Particle Diameter and Particle Mass Density

each of disk , rod and spherical shaped microparticles in a

Average Particle

Particle Type
PLGA

PLGA -Gel
PLGA - FN

PLGA -PEG
PLGA - PEG -Gel

PLGA-PEG -FN

Diameter

No. of Particles/ g

183 + 70 .0 um

222 ,600

214 67.0 um
233 = 37 .8 um
161 = 30 . 1 um
162 = 43. 3 um
180 = 42.5 um

bioreactor at 37° C . and 5 % CO ,. After 24 h , a fluorescence

microscope using DAPI nuclear stain imaged cell attach
ment. The number of live cells were quantified , and com

139 , 200
107, 850
326 , 900
320 , 900
233, 900

pared .
10065 ] FIG . 6 depicts fluorescence microscope images of

[0062 ] The conjugation efficiency of fibronectin binding
to PLGA and PLGA -PEG particles was determined using

the Bradford Protein Assay. Fibronectin was found to bind

with 90 % efficiency . Results are shown in Table 2 . Free
protein describes protein that did not bind to the micropar
ticle .

a model cell line (HUVEC ), grown on (a ) a tissue -culture
treated plate (control); (b ) gelatin -coated tissue culture plate
( control) ; (c ) PLGA spheres ; ( d ) PLGA disks; ( e ) gelatin
coated PLGA spheres ; and (f) collagen -coated PLGA
spheres. The blue fluorescence indicates cell nuclei. FIG . 7
is a graph of HUVEC growth on various particle shapes.
Microparticles enhance the expansion of HUVEC . Disks
show 1. 4 fold more HUVEC growth than spheres . The
attachment of cells to a microparticle surface is often seen as

TABLE 2
Fibronectin conjugation efficiency
Mass
Particle

PLGA

PLGA- PEG

Protein Initial
116 ug

116 ug

Mass of

Free Protein

Mass Protein
Conjugated

Conjugation
Efficiency

Fibronectin Study
7 .02 + 3.44 ug 109 3 .44 ug 94 .0 + 2 .97 %

Protein Density
(ug Protein /
cm ? Particle )
28 . 2 + 0 . 890

5.13 1.03 ug 111 - 1.03 ug 95.6 0.888 % 22.2 - 0.206

[ 0063] Fibronectin and gelatin were conjugated to the
surface of both PLGA and PLGA-PEG particle types to
improve the particle's association with fibroblast cells. The

a basic characteristic .However , themicroparticles geometry
may subsequently influence and regulate the cell growth and
survival.
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[0066 ] From the foregoing it will be seen that this inven

tion is one well adapted to attain all ends and objectives
herein -above set forth , together with the other advantages
which are obvious and which are inherent to the invention .
[ 0067

Since many possible embodiments may be made of

the invention without departing from the scope thereof, it is

to be understood that all matters herein set forth or shown in
the accompanying drawings are to be interpreted as illus -
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9 . Themethod of claim 8 , wherein the ratio of the organic

solution to the first aqueous solution is 1: 2 to 1: 4 .
10 . The method of claim 1 , wherein the ratio of the
organic solution to the first aqueous solution to the second

aqueous solution is from 1: 1 :5 to 1 :5 : 25.
11 . The method of claim 1, further comprising after said

introducing step , stirring the second aqueous solution .

12 . The method of claim 1 , further comprising after said

trative , and not in a limiting sense .
[0068 ] While specific embodiments have been shown and

removing step , lyophilizing the PLGA microparticles.

discussed , various modifications may of course be made ,

removing step, the step of stretching the PLGA micropar

and the invention is not limited to the specific forms or
arrangement of parts and steps described herein , except
insofar as such limitations are included in the following

claims. Further, it will be understood that certain features

and subcombinations are of utility and may be employed

without reference to other features and subcombinations .
This is contemplated by and is within the scope of the

claims.

What is claimed and desired to be secured by Letters
Patent is as follows:

1. A method for forming microparticles useful for cell
obtaining an organic solution comprising poly (D ,L -lac
tide-co - glycolide) (PLGA);
obtaining a first aqueous solution comprising polyvinyl
alcohol (PVA );
obtaining a second aqueous solution comprising PVA in a

seeding comprising :

higher concentration than said first aqueous solution ;
co - injecting a stream of the organic solution and a carrier

stream of the first aqueous solution into a flow focusing

13. The method of claim 1, further comprising after said

ticles into microdisks and microrods.

14 . A method of conjugating a cell binding protein to

surfaces of poly (D ,L -lactide-co - glycolide ) (PLGA)
microparticles comprising :
obtaining PLGA microparticles formed from the process
of claim 1 ;
suspending the PLGA microparticles in an aqueous buffer
solution at pH from 5 .5 to 6 .5 ;
activating carboxyl groups on the surfaces of the PLGA
microparticles;
adding the protein to form a mixture of the microparticles

and the protein at a pH above 7 .0 ;
shaking the mixture to conjugate the protein to the sur
faces of the PLGA microparticles; and
removing unreacted reagents .
15 . The method of claim 14 , wherein the ratio of the

PLGA microparticles to the buffer solution is 1 : 1 to 25 : 1
( w / v ).

16 . The method of claim 14 , wherein the protein is

tube to form organic droplets within the carrier stream ;

selected from the group consisting of fibronectin , gelatin ,

droplets into the second aqueous solution to form

17 . The method of claim 14 , wherein the PLGA micropar
ticles comprise PLGA -PEG microparticles.

solution ;

6 . The method of claim 1 , wherein the concentration of

18 . The method of claim 14 , wherein said removing step
comprises centrifugation , filtration or combinations thereof.
19 . A method of conjugating a cell binding protein to
surfaces of poly (D ,L -lactide-co - glycolide ) (PLGA)
microparticles comprising:
obtaining PLGA microparticles;
suspending the PLGA microparticles in an aqueous buffer
solution at pH from 5.5 to 6 .5 ;
activating carboxyl groups on the surfaces of the PLGA
microparticles ;
adding the protein at a pH above 7.0 ;
shaking the PLGAmicroparticles and protein to conjugate

7 . The method of claim 1, wherein the concentration of
PVA in the second aqueous solution is from 1 % (w / v ) to
10 % (w / v ) .

and
removing unreacted reagents .
20 . Themethod of claim 19 , wherein the PLGAmicropar

introducing the carrier stream comprising the organic

microparticles of the PLGA in the second aqueous

evaporating the organic solvent; and
removing the PVA .
2 . The method of claim 1 , wherein the ratio of the PLGA

to the organic solvent is from 1 % ( w /v ) to 25 % (w / v ).
3 . The method of claim 2 , wherein the ratio of the PLGA

to the organic solvent is from 5 % ( w / v ) to 15 % ( w /v ).
4 . The method of claim 1 , wherein the organic solution

further comprises polyethylene glycol (PEG ).

5 . The method of claim 4 , wherein the ratio of PLGA to
PEG is greater than 70 : 1 .
PVA in the first aqueous solution is from 1 % ( w / v ) to 10 %
( w /v ).

8 . The method of claim 1 , wherein the ratio of the organic

solution to the first aqueous solution is 1 : 1 to 1: 10 .

collagen , laminin and peptides .

the protein to the surfaces of the PLGA microparticles ;

ticles comprise PLGA - PEG microparticles .
*
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